Osaic Holdings
EVOK

Osaic Holdings’s Evoke Pharma EVOK Stock Holding History

Osaic Holdings’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,010
Closed -$16.4K – 7948
2025
Q3 		$16.4K Buy
+3,010
New +$14.9K ﹤0.01% 6060
2022
Q3 		– Sell
-3
Closed – – 7318
2022
Q2 		$0 Hold
3
– – ﹤0.01% 7412
2022
Q1 		$0 Hold
3
– – ﹤0.01% 7305
2021
Q4 		$0 Hold
3
– – ﹤0.01% 7428
2021
Q3 		$1K Hold
3
– – ﹤0.01% 7010
2021
Q2 		$1K Hold
3
– – ﹤0.01% 6843
2021
Q1 		$1K Hold
3
– – ﹤0.01% 6642
2020
Q4 		$1K Hold
3
– – ﹤0.01% 6202
2020
Q3 		$2K Hold
3
– – ﹤0.01% 5844
2020
Q2 		$2K Buy
+3
New +$835 ﹤0.01% 5776

Osaic Holdings's EVOK Position: Q4 2025 in Review

Osaic Holdings sold out of Evoke Pharma (EVOK) in Q4 2025, closing a stake of 3,010 shares — an estimated $16.4K sold.

Osaic Holdings first reported a position in EVOK in Q2 2020 and held it in 10 quarters. The position peaked at $16.4K in Q3 2025. 0 funds tracked by Wall St. Rank hold EVOK as of Q4 2025.

  • Osaic Holdings reported no remaining Evoke Pharma position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 3,010 Evoke Pharma shares in Q4 2025, an estimated $16.4K.
  • Osaic Holdings first reported a position in Evoke Pharma in Q2 2020 and held it in 10 quarters.
  • Osaic Holdings's Evoke Pharma position peaked at $16.4K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.